Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedSep 18, 2013B12/E2/E3/PROG/TEST 1/3.75/2.5/50/45 MG/ML OIL INJ SOLNLack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance.Beacon Hill Medical Pharmacy, P.C. · D-940-2013Class IITerminatedSep 18, 2013B-COMPLEX/LIDOCAINE 2% INJECTIONLack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-939-2013Class IITerminatedSep 18, 2013ARGININELack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-938-2013Class IITerminatedSep 18, 2013ALPROSTADILLack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-937-2013Class IITerminatedSep 18, 2013B-COMPLEX/LIDO/B-12Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-936-2013Class IITerminatedSep 18, 2013B-12/LIDOCAINE 25/10MG/MLLack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-935-2013Class IITerminatedSep 18, 2013ASCORBIC ACIDLack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-934-2013Class IITerminatedSep 18, 2013ACETYLCYSTEINE 100 MG/ML INJ SOLNLack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-933-2013Class IITerminatedSep 18, 2013Propofol Injectable EmulsionPresence of Particulate Matter: Visible particulate embedded in the glass vial was observed and confirmed in a sample bottle during retain sample inspection.Hospira Inc. · D-932-2013Class IITerminatedSep 18, 2013EFFERVESCENT POTASSIUM/CHLORIDE TABLETSLABELING: Label Mix-up: 30 count Effervescent Potassium/Chloride Tablets, may be labeled as 30 count K Effervescent Tablets.Qualitest Pharmaceuticals · D-1037-2013Class IITerminatedSep 18, 2013K EFFERVESCENT TABLETSLABELING: Label Mix-up: 30 count Effervescent Potassium/Chloride Tablets, may be labeled as 30 count K Effervescent Tablets.Qualitest Pharmaceuticals · D-1036-2013Class IITerminatedSep 18, 2013Dexpanthenol 250 mg/mL PFLack of Assurance of Sterility: The product lots are being recalled due to laboratory results indicating microbial contamination. The FDA was concerned test results...Wellness Pharmacy, Inc. · D-1035-2013Class IITerminatedSep 18, 2013RL Glutathione 100 mg/mLLack of Assurance of Sterility: The product lots are being recalled due to laboratory results indicating microbial contamination. The FDA was concerned test results...Wellness Pharmacy, Inc. · D-1034-2013Class IITerminatedSep 18, 2013NA. Phenylbutyrate 200 mg/mLLack of Assurance of Sterility: The product lots are being recalled due to laboratory results indicating microbial contamination. The FDA was concerned test results...Wellness Pharmacy, Inc. · D-1033-2013Class IITerminatedSep 18, 2013Methyl B12 1 mg/mL P.FLack of Assurance of Sterility: The product lots are being recalled due to laboratory results indicating microbial contamination. The FDA was concerned test results...Wellness Pharmacy, Inc. · D-1032-2013Class IITerminatedSep 18, 2013Magnesium Sulfate Hepta 50% PFLack of Assurance of Sterility: The product lots are being recalled due to laboratory results indicating microbial contamination. The FDA was concerned test results...Wellness Pharmacy, Inc. · D-1031-2013Class IITerminatedSep 18, 2013Dexpanthenol 250mg/ml PFThe product lots are being recalled due to laboratory results indicating microbial contamination. The FDA was concerned test results obtained from the recalling firm's...Wellness Pharmacy, Inc. · D-1030-2013Class IITerminatedSep 18, 2013EDTA disodium 150 mg/mL Sterile InjectionLack of Assurance of Sterility: Pharmacy Creations is recalling Lidocaine 1% PF Sterile Injection and EDTA disodium 150 mg/mL due to lack of assurance of sterility.Pharmacy Creations · D-1029-2013Class IITerminatedSep 18, 2013Lidocaine 1% PF Sterile InjectionLack of Assurance of Sterility: Pharmacy Creations is recalling Lidocaine 1% PF Sterile Injection and EDTA disodium 150 mg/mL due to lack of assurance of sterility.Pharmacy Creations · D-1028-2013Class IITerminatedSep 18, 2013Testosterone CypionateLack of Assurance of Sterility: Park Compounding is voluntarily recalling two lots of Methylcobalamin 5mg/ml and Multitrace-5 Concentrate, and one lot of Testosterone...South Coast Specialty Compounding, Inc. · D-1027-2013Class IITerminatedSep 18, 2013Multitrace-5 ConcentrateLack of Assurance of Sterility: Park Compounding is recalling Methylcobalamin 5 mg/mL, Multitrace-5 Concentrate, and Testosterone Cypionate (sesame oil) for injection...South Coast Specialty Compounding, Inc. · D-1026-2013Class IITerminatedSep 18, 2013Methylcobalamin Injection 5 mg/mLLack of Assurance of Sterility: Park Compounding is recalling Methylcobalamin 5 mg/mL, Multitrace-5 Concentrate, and Testosterone Cypionate (sesame oil) for injection...South Coast Specialty Compounding, Inc. · D-1025-2013Class IITerminatedSep 18, 2013PGE-1, 100 mcg/mL Injection in Normal SalineLack of Assurance of Sterility: University Compounding Pharmacy is voluntarily recalling certain pharmacy products due to lack of assurance of sterility concerns.University Compounding Pharmacy · D-1024-2013Class IITerminatedSep 18, 2013PGE-1, 20 mcg/mL Injection in Normal SalineLack of Assurance of Sterility: University Compounding Pharmacy is voluntarily recalling certain pharmacy products due to lack of assurance of sterility concerns.University Compounding Pharmacy · D-1023-2013Class IITerminatedSep 18, 2013Testosterone Cypionate/Testosterone Propionate 180-20 mg/mL InjectionLack of Assurance of Sterility: University Compounding Pharmacy is voluntarily recalling certain pharmacy products due to lack of assurance of sterility concerns.University Compounding Pharmacy · D-1022-2013Class IITerminatedSep 18, 2013Testosterone CYPLack of Assurance of Sterility: University Compounding Pharmacy is voluntarily recalling certain pharmacy products due to lack of assurance of sterility concerns.University Compounding Pharmacy · D-1021-2013Class IITerminatedSep 18, 2013Testosterone CypionateLack of Assurance of Sterility: University Compounding Pharmacy is voluntarily recalling certain pharmacy products due to lack of assurance of sterility concerns.University Compounding Pharmacy · D-1020-2013Class IITerminatedSep 18, 2013Glutathione 100 mg/mL InjectableGlutathione 100 mg/mL injectable human drug is recalled due to Out Of Specification results or potential bacterial contamination and it was reported as passing by a...Creative Compounds · D-1019-2013Class IITerminatedSep 18, 2013MANGANESE SULFATE 0.1 MG/ML INJECTABLELack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-1018-2013Class IITerminatedSep 18, 2013CALCIUM EDTA 300 MG/ML INJECTABLELack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-1017-2013Class IITerminatedSep 18, 2013CALCIUM EDTA 200 MG/ML INJECTABLELack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-1016-2013Class IITerminatedSep 18, 2013BUPRENORPHINE 0.1/0.05 MG/ML CREAMLack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-1015-2013Class IITerminatedSep 18, 2013B-12 REJUV 25 MG/ML INJECTABLELack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-1014-2013Class IITerminatedSep 18, 2013ASCORBIC ACIDLack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-1013-2013Class IITerminatedSep 18, 2013ALPROSTADIL 100 MCG/ML INJ SOLNLack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-1012-2013Class IITerminatedSep 18, 2013Zinc Sulfate 1 mg/ml INJECTABLELack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-1011-2013Class IITerminatedSep 18, 2013VITAMIN D 50Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-1010-2013Class IITerminatedSep 18, 2013VITAMIN B-COMPLEX INJECTABLELack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-1009-2013Class IITerminatedSep 18, 2013TRIPTROPIN PLUS INJECTABLELack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-1008-2013Class IITerminatedSep 18, 2013TRIPLE-TESTOSTERONE 250 MG/ML OIL INJ SOLN and TRIPLE-TESTOSTERONE 200 MG/ML OIL INJ SOLNLack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-1007-2013